Nav: Home

Plant 'chemical factory' could produce variety of commercial products

December 05, 2016

A 'chemical factory' on the surface of plant leaves could help produce more commercially useful products, researchers at the University of York have found.

The team found that the final stages of the production of artemisinin, a substance used in anti-malarial drugs and naturally harvested from the plant, Artemisia annua, is a spontaneous process and does not involve the actions of proteins to trigger a chemical reaction.

This spontaneous process means that a very particular chemical environment must be created in order to produce and store often toxic chemicals in the plant.

The findings, published in the journal, PNAS, suggest that companies could potentially utilise this 'chemical factory' system within the plant itself for use in the production of a whole host of chemical-based products, such as anti-bacterial gels, fragrances, natural sweeteners, and compounds to aid food crop production.

Professor Ian Graham, who led the research at the University of York's Department of Biology, explains: "Plants make lots of high value compounds but often in very small amounts. To produce these compounds on a commercial scale industrial biotechnologists aim to transfer the whole production process from plants to yeast cells which can then be grown at scale in large fermenters.

"Many of the valuable plant compounds, however, can be toxic to yeast cells. Our new findings, suggests that we may have a solution to this problem."

The study shows that the 'chemical factory', called glandular trichomes, not only produces complex chemicals, but can store them without being toxic to the plant.

The team also found that the pathway that produces artemisinin can be diverted to make entirely new products. The researchers argue that using the plant itself as the 'factory' can work in creating products on a commercial scale.

Dr Tomasz Czechowski, co-author of the research paper at the University of York, said: "We have shown that Artemisia annua not only produces the most effective medicine to cure people suffering form malaria but it can also be altered to produce other complex molecules, which is an exciting discovery.

"We now know that it employs a very sophisticated system that stores complex chemicals that could be used in many other products. This could pave the way for other plant-based products being made naturally within the plant itself."
-end-


University of York

Related Biology Articles:

Cell biology: Compartments and complexity
Ludwig-Maximilians-Universitaet (LMU) in Munich biologists have taken a closer look at the subcellular distribution of proteins and metabolic intermediates in a model plant.
Cell biology: The complexity of division by two
Ludwig-Maximilians-Universitaet (LMU) in Munich researchers have identified a novel protein that plays a crucial role in the formation of the mitotic spindle, which is essential for correct segregation of a full set of chromosomes to each daughter cell during cell division.
Cell biology: Dynamics of microtubules
Filamentous polymers called microtubules play vital roles in chromosome segregation and molecular transport.
The biology of color
Scientists are on a threshold of a new era of color science with regard to animals, according to a comprehensive review of the field by a multidisciplinary team of researchers led by professor Tim Caro at UC Davis.
Kinky biology
How and why proteins fold is a problem that has implications for protein design and therapeutics.
More Biology News and Biology Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...